Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
Subscribe To Our Newsletter & Stay Updated
